| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 48,586 | 47,024 | 50,015 | 44,381 | | Cost of Revenue | 38,466 | 38,300 | 41,485 | 42,438 | | | Gross Profit | 10,120 | 8,724 | 8,530 | 1,943 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,182 | 6,444 | 6,065 | 4,867 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,938 | 2,280 | 2,465 | (2,924) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (913) | 900 | 13 | 3 | | Earnings Before Interest And Taxes | 4,025 | 3,180 | 2,478 | (2,921) | | Interest Expense | 407 | 476 | 424 | 140 | | Income Before Tax | 3,618 | 2,704 | 2,054 | (3,061) | | Income Tax Expense | 1,122 | 748 | 653 | (1,280) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,496 | 1,956 | 1,401 | (1,781) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,496 | 1,956 | 1,401 | (1,781) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,496 | $1,956 | $1,401 | ($1,781) |
|
0.02% Nasdaq 0.00%
Income Statement
